Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2026-01-16 @ 5:17 PM
Study NCT ID:
NCT00680992
Status:
COMPLETED
Last Update Posted:
2022-09-22
First Post:
2008-05-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
Sponsor:
Amgen
Organization:
Study Overview
Official Title:
An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects With Giant Cell Tumor of Bone
Status:
COMPLETED
Status Verified Date:
2022-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine how safe denosumab is in treating subjects with giant cell tumor of bone (GCTB)
Detailed Description:
To determine how safe denosumab is in treating subjects with GCTB
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: